We are live on ! Find out more
SIBN icon

SI-BONE Inc

66 hedge funds and large institutions have $225M invested in SI-BONE Inc in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

6% more funds holding

Funds holding: 6266 (+4)

5.88% more ownership

Funds ownership: 45.53%51.41% (+5.9%)

1% less capital invested

Capital invested by funds: $227M → $225M (-$2.07M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
66
Holders Change
+4
Holders Change %
+6.45%
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
10
Increased
24
Reduced
18
Closed
6
Calls
Puts
Net Calls
Net Calls Change

SIBN Hedge Fund Activity: Q3 2019 in Review

66 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in SI-BONE Inc (SIBN) for Q3 2019, worth a combined $225M — down 0.91% from $227M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SIBN positions and 6 closed out — a net gain of 4 holders — while 24 added to existing stakes and 18 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $12.6M. The largest seller was OrbiMed, cutting an estimated $10.8M.

  • 66 institutional investors held SI-BONE Inc (SIBN) as of Q3 2019, up from 62 in Q2 2019.
  • Funds reported $225M of SI-BONE Inc stock for Q3 2019, down 0.91% quarter-over-quarter.
  • 10 funds opened new SI-BONE Inc positions in Q3 2019 and 6 closed out, a net change of +4 holders.
  • The largest SI-BONE Inc buyer in Q3 2019 was Gilder Gagnon Howe & Co, an estimated $12.6M added.
  • The largest SI-BONE Inc seller in Q3 2019 was OrbiMed, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2019.